Noetic Fund

Noetic Fund is a Toronto-based venture capital firm founded in 2020 that invests globally in emerging technologies within molecular therapeutics/biotech, digital health, medical devices, and wellness sectors. It has a particular emphasis on mental health, pain management, and central nervous system-related complications. The fund supports early-stage to growth-stage companies developing innovative therapies—especially those leveraging psychedelic compounds or novel delivery systems—to address unmet needs in psychiatry and beyond. Portfolio highlights include investments in Beckley Psytech (psychedelic-based depression therapy), Bexson Biomedical (subcutaneous ketamine for pain), Eleusis Holdings (psilocybin for depression), Compass Pathways (mental health innovation), Cybin Corp., Apollo Neuroscience, among others[4][5][9].